ArticleCellular signalling2025

An inhibitor of UHM splicing factors exerts anti-leukemic activity by altering cell cycle progression and reducing lysosome acidification.

Mona Kazemi Sabzvar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.